To study the effect of two medicines Amlodipine and Labetolol in controlling blood pressure in delivered patients
Not Applicable
- Conditions
- Health Condition 1: O135- Gestational [pregnancy-induced] hypertension without significant proteinuria, complicating the puerperiumHealth Condition 2: O140- Mild to moderate pre-eclampsia
- Registration Number
- CTRI/2020/02/023236
- Lead Sponsor
- Jawahalal Nehru Institute of Postgraduate Medical Education and Research
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Postpartum women fulfilling all the criteria below:
1.Age more than 18years
2.Women who were antenatal diagnosed to have hypertensive disorders of pregnancy using ACOG criteria in whom the treating team intend to stop antihypertensive therapy after delivery
3.At any time before discharge from hospital blood pressure reading of
a.more than or equal to 150/100 mm of Hg on 2 occasions
or
b.more than or equal to 160/110 mm of Hg on 1occasion
Exclusion Criteria
1. Known case of AV heartblock
2. Heart rate <60 or >120 beats perminute
3. Serum creatinine more than or equal to 1.5mg/dl)
4. Heartfailure & pulmonary edema
5. Asthma
6. Eclampsia, HELLP syndrome
7. Critically ill on mechanical ventilation or invasive hemodynamic
monitoring
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method